Observing cognitive impairment in older adults
Official title: Cognitive Impairment in Ageing People: A Longitudinal Observational Prospective Study
Run by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT04360200 · Data updated 2026-11-12
This study looks at older adults to see how mild cognitive impairment and dementia develop, hoping to find better ways to prevent and treat these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 5000 (estimated) |
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | April 1, 2020 |
| Main results expected | December 2040 |
| Study ends | December 2040 |
| Registry record updated | September 14, 2020 |
| Trial ID | NCT04360200 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals over 50 years old who show signs of mild cognitive impairment but do not meet the full criteria for dementia.
✕Probably not a fit
Patients with severe mental illness, significant physical disabilities, or those who refuse necessary examinations may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on understanding mild cognitive impairment (MCI) and neurocognitive disorders such as Alzheimer's disease and vascular dementia in elderly populations. It aims to establish a prospective cohort to gather comprehensive epidemiological data and biological samples, which will aid in early prevention, diagnosis, and treatment of cognitive disorders. The study will utilize gene and brain imaging biomarkers to enhance the understanding of dementia pathogenesis and improve targeted interventions. By addressing the rising burden of dementia in China, the study seeks to provide valuable insights into this public health issue.
Why it matters
Potential benefit: If successful, this study could lead to improved early diagnosis and treatment strategies for cognitive impairments in the elderly.
How similar studies have gone: Other studies focusing on cognitive impairment and dementia have shown promise in utilizing biomarkers for diagnosis and intervention, indicating that this approach is supported by previous research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients over 50 years old. 2. Sign informed consent. 3. According to DSM-IV, the diagnostic standard of dementia was not met. 4. The clinical dementia rating (CDR) was 0.5. Exclusion criteria: 1. Subjects with mental retardation. 2. Refuse to have blood sampling, imaging and other examinations. 3. Uncooperative subjects that have serious organic diseases, or have a history of mental illness, or have physical disability (including severe aphasia). 4. Contraindications of MR scanning. 5. Suffering from serious physical or mental illness.
Where it's running
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Yamei Tang
- Email: yameitang@hotmail.com
- Phone: +86-020-34070569
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease
A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.
-
Digital platform for early detection of Alzheimer-related memory impairment
The platform will be tested to see if combining EEG, eye-tracking, and blood flow sensors can detect early memory-related cognitive impairment in people aged 55–80.
-
Omics-based profiling to find disease mechanisms and biomarkers in Alzheimer’s, Parkinson’s, FTD, and related dementias
This project will use advanced omics tests (genetics, gene expression, proteins, and metabolites) to try to find biological markers and disease mechanisms in people with Alzheimer’s, Parkinson’s, frontotemporal and young-onset dementias, or mild cognitive impairment.
-
Lifestyle for Brain Health — Time-Restricted Eating and Mindfulness
This 9-month program tests whether combining yoga-based mindfulness with time-restricted eating improves cognition, physical fitness, metabolism, and plasma tau levels in adults 60–80 with subjective or mild cognitive impairment and positive pTau217.
-
Nutrition and exercise program for brain health in older adults
This study tests whether a 9-month program of exercise and nutrition can help improve brain health and physical function in older adults at risk for Alzheimer's disease.
-
Hearing care to reduce neuropsychiatric symptoms in people with Alzheimer's and related dementias
This trial will try a tailored, community-delivered hearing care program using HEARS devices to see if it improves communication, reduces neuropsychiatric symptoms, and eases caregiver distress in English-speaking older adults with Alzheimer's disease or related dementias who have untreated hearing loss.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.